Clinical trial update
New Clinical Trial for SCN1A-Related Genetic Epilepsy
A new phase 2 clinical trial is testing a targeted medication for children with Dravet Syndrome and other SCN1A-related conditions.
Source: ClinicalTrials.gov
Epilepsy is a neurological condition defined by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. It affects approximately 470,000 children in the United States and is particularly prevalent among children with neurodevelopmental conditions such as Rett Syndrome, Dravet Syndrome, TSC, and CDKL5 deficiency. Treatment options span anti-seizure medications (ASMs), the ketogenic diet, vagus nerve stimulation, responsive neurostimulation, and resective surgery for drug-resistant epilepsy. Emerging gene therapies and precision medicine approaches are in active clinical trials. SpecialCircle Research summarises the latest studies and FDA approvals in plain language - helping parents understand what options exist and what questions to raise with neurologists.
Clinical trial update
A new phase 2 clinical trial is testing a targeted medication for children with Dravet Syndrome and other SCN1A-related conditions.
Source: ClinicalTrials.gov
Gene therapy
A 'one-shot' viral gene therapy has been developed to restore a critical protein needed for brain development in MEF2C-related disorders.
Source: National Institutes of Health (NIH)
Guideline update
A large group of medical experts created the first consensus-based care guidelines for Rett syndrome, covering the full lifespan from childhood through adulthood.
Source: BMJ Paediatrics Open
Epilepsy is a neurological condition defined by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. It affects approximately 470,000 children in the United States and is particularly prevalent among children with neurodevelopmental conditions such as Rett Syndrome, Dravet Syndrome, TSC, and CDKL5 deficiency. Treatment options span anti-seizure medications (ASMs), the ketogenic diet, vagus nerve stimulation, responsive neurostimulation, and resective surgery for drug-resistant epilepsy. Emerging gene therapies and precision medicine approaches are in active clinical trials. SpecialCircle Research summarises the latest studies and FDA approvals in plain language - helping parents understand what options exist and what questions to raise with neurologists. SpecialCircle Research summarises studies from PubMed, NIH, FDA, and ClinicalTrials.gov in plain language for parents. This is not medical advice.
Talk to parents who truly understand
SpecialCircle is a free, private community. Ask questions, share what works, and never feel alone.
We use cookies to operate this site and improve your experience. See our Cookie Policy.